Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.
Year: 1997
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: A Ardizzoni, H Hansen, P Dombernowsky, T Gamucci, S Kaplan, P Postmus, G Giaccone, B Schaefer, J Wanders, J Verweij
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1919288105